Literature DB >> 32239471

Provision of Italian diagnostic reference levels for diagnostic and interventional radiology.

Gaetano Compagnone1, Renato Padovani2, Loredana D'Ercole3, Antonio Orlacchio4, Guglielmo Bernardi5, Maria Antonietta D'Avanzo6, Sveva Grande7, Alessandra Palma7, Francesco Campanella6, Antonella Rosi7.   

Abstract

OBJECTIVES: The diagnostic reference level (DRL) is a useful tool for the optimisation of medical exposures. Thus, a Working Party coordinated by the Italian National Institute of Health and the National Workers Compensation Authority has been formed to provide Italian DRLs, for both diagnostic and interventional procedures, to be used as appropriate for the implementation of the 2013/59 European Directive into the national regulation.
MATERIALS AND METHODS: The multidisciplinary Working Party was formed by professionals involved in diagnostic and interventional radiology medical exposures and started from a critical revision of both the literature and the results of previous Italian surveys. The procedures were divided into five sections for adult (projection radiography, mammography, diagnostic fluoroscopy, CT and interventional radiology) and two sections for paediatric patients (projection radiography and CT). The provided DRL values have been identified for "normal" adult patients and for age-classes of paediatric patients.
RESULTS: Some of the DRL values provided by the Working Party are reported in this study as an example, divided by adult/paediatric patients, radiological technique and examination: specifically, DRLs for new radiological practices and new dose quantities as DRLs metric were introduced. The median value (rather than the mean) for each procedure, derived from a sample of patients, has to be compared with the corresponding DRL value, and dosimetric data related to a minimum number of patients should be collected for each examination.
CONCLUSIONS: The approach to the definition and use of DRLs through guidelines of national Authorities in collaboration with scientific Associations should simplify the periodical updating and could be useful for keeping the optimisation of medical exposures faithful to the development of radiological practice.

Entities:  

Keywords:  Diagnostic radiology; Diagnostic reference level; Interventional radiology; Optimisation; Patient dose; Radiation protection

Year:  2020        PMID: 32239471     DOI: 10.1007/s11547-020-01165-3

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  4 in total

Review 1.  Lymph Nodes Evaluation in Rectal Cancer: Where Do We Stand and Future Perspective.

Authors:  Alessandra Borgheresi; Federica De Muzio; Andrea Agostini; Letizia Ottaviani; Alessandra Bruno; Vincenza Granata; Roberta Fusco; Ginevra Danti; Federica Flammia; Roberta Grassi; Francesca Grassi; Federico Bruno; Pierpaolo Palumbo; Antonio Barile; Vittorio Miele; Andrea Giovagnoni
Journal:  J Clin Med       Date:  2022-05-05       Impact factor: 4.964

Review 2.  Precision Imaging Guidance in the Era of Precision Oncology: An Update of Imaging Tools for Interventional Procedures.

Authors:  Chiara Floridi; Michaela Cellina; Giovanni Irmici; Alessandra Bruno; Nicolo' Rossini; Alessandra Borgheresi; Andrea Agostini; Federico Bruno; Francesco Arrigoni; Antonio Arrichiello; Roberto Candelari; Antonio Barile; Gianpaolo Carrafiello; Andrea Giovagnoni
Journal:  J Clin Med       Date:  2022-07-12       Impact factor: 4.964

Review 3.  Imaging Features of Post Main Hepatectomy Complications: The Radiologist Challenging.

Authors:  Carmen Cutolo; Federica De Muzio; Roberta Fusco; Igino Simonetti; Andrea Belli; Renato Patrone; Francesca Grassi; Federica Dell'Aversana; Vincenzo Pilone; Antonella Petrillo; Francesco Izzo; Vincenza Granata
Journal:  Diagnostics (Basel)       Date:  2022-05-26

4.  Application of reference air kerma alert levels for pediatric fluoroscopic examinations.

Authors:  Elanchezhian Somasundaram; Samuel L Brady; Keith J Strauss
Journal:  J Appl Clin Med Phys       Date:  2022-08-04       Impact factor: 2.243

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.